N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
申请人:ARRAY BIOPHARMA, INC.
公开号:US10780073B2
公开(公告)日:2020-09-22
This invention provides compounds of Formula I
wherein B, G, A, E, R1, R2, R3, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.
本发明提供了式 I 的化合物
其中 B、G、A、E、R1、R2、R3、m 和 n 如本文所定义,可用作 I 型受体酪氨酸激酶抑制剂,并可用于治疗哺乳动物的过度增殖性疾病。